Wed, August 7, 2024

Emmanuel Papadakis Upgraded (BNTX) to Strong Buy and Held Target at $95 on, Aug 7th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-95-on-aug-7th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Emmanuel Papadakis of Deutsche Bank, Upgraded "BioNTech SE" (BNTX) to Strong Buy and Held Target at $95 on, Aug 7th, 2024.

Emmanuel has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 2 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024
  • Cory Kasimov of "Evercore ISI Group" Initiated at Hold and Held Target at $100 on, Tuesday, May 14th, 2024


These are the ratings of the 3 analyists that currently disagree with Emmanuel


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $113 on, Thursday, August 1st, 2024
  • Jessica Fye of "JP Morgan" Maintained at Sell with Increased Target to $94 on, Wednesday, June 12th, 2024
  • Etzer Darout of "BMO Capital" Maintained at Buy with Decreased Target to $122 on, Tuesday, May 7th, 2024

Publication Contributing Sources